Evidence map›Paper›PMID 42145629›Full record

ArticlemedRxiv : the preprint server for health sciences2026

Enhanced Adverse-Event Detection and Drug-Event Relation Extraction from Clinical Notes.

Omar Alharbi, Cathy H Wu, Chuming Chen, K Vijay-Shanker

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Omar AlharbiCenter for Bioinformatics and Computational Biology, University of Delaware, Newark, DE, USA.ORCID 0009-0003-5305-3317
Cathy H WuCenter for Bioinformatics and Computational Biology, University of Delaware, Newark, DE, USA.ORCID 0000-0001-6379-8601
Chuming ChenCenter for Bioinformatics and Computational Biology, University of Delaware, Newark, DE, USA.ORCID 0000-0002-7287-9013
K Vijay-ShankerDepartment of Computer and Information Sciences, University of Delaware, Newark, DE, USA.ORCID 0000-0003-0958-3073

Funding

Predictive Modeling & Optimal Control Framework for Model-Based Epidemic Response in DelawareP20GM103446 · NIGMS · UNIVERSITY OF DELAWARE · PI Anjana Narayan Bhat · 2012 to 2026
$67.2M
Subproject Title: Clinical Research Education, Mentoring and Career Development CoreU54GM104941 · NIGMS · UNIVERSITY OF DELAWARE · PI Gregory E Hicks · 2013 to 2026
$60.5M
NIGMS NIH HHS P20 GM103446NIGMS NIH HHS U54 GM104941
6 · The paper itself

Abstract

Adverse drug events (ADEs) are a significant source of preventable patient harm, yet many ADE signals remain buried in free-text clinical notes. Clinical notes often describe adverse events (AEs) in relation to drugs in two ways: whether a drug causes the AE (the AE is an ADE) or a drug is given to treat an AE (it is considered the Reason for drug treatment). In the N2C2 2018 benchmark, ADEs and Reasons are annotated as separate entity types, despite often being similar in both wording and clinical meaning. This shared similarity makes them difficult to distinguish during entity extraction, leading to errors in relation classification. Therefore, we propose a two-stage framework that first detects AEs as a unified event category and then classifies drug-event pairs into Drug-ADE, Drug-Reason, or No-Relation. In the end-to-end evaluation on the N2C2 2018 benchmark, our system achieves F1 scores of 0.93 for Drug-ADE and 0.94 for Drug-Reason, improving over previously reported end-to-end benchmarks of 0.48 for Drug-ADE and 0.59 for Drug-Reason. Overall, these results support a more precise task formulation in which AEs are detected broadly first, and the ADE vs Reason distinction is resolved at the relation layer. Furthermore, they motivate the development of AE-focused datasets annotated independently of drug linkage to enable more reliable end-to-end pharmacovigilance systems.

Indexed as

ADEAdverse drug eventAdverse eventsAEclinical notespharmacovigilancerelation extraction

Identifiers

PMID42145629
PMCPMC13174705

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.